Salt Lake City and Atlanta, Nov. 10, 2020 /PRNewswire/ — CenExel Clinical Research (“CenExel”) announced that Stanford R. Plavin, MD, DABA, has joined Atlanta Center for Medical Research (ACMR), a CenExel Center of Excellence, as a principal investigator for clinical studies in several therapeutic categories including acute pain and vaccines. Dr. Plavin’s expertise will expand clinical research capabilities at ACMR to outpatient surgical procedures where anesthesiology is required and help inform study design and protocol development.
Dr. Plavin, a Diplomate of the American Board of Anesthesiology (ABA), is owner and co-founder of Technical Anesthesia Strategies and Solutions LLC, a medical consulting and advisory firm, and founder of Ambulatory Anesthesia Partners LLC, an Atlanta-based physician practice. His continued operation of these practices will augment the ACMR network for recruiting study participants for several therapeutic areas, including acute pain.
Dr. Plavin received his Doctor of Medicine degree from the University of Vermont College of Medicine and completed his residency in anesthesiology at Emory University affiliated hospitals. He is licensed in medicine and surgery in multiple states, including Georgia and South Carolina. He has been an active speaker and lecturer at scientific meetings since 2011 and has published several peer-reviewed articles on surgery and anesthesia-related topics.
“I have functioned as a medical director and consultant to many outpatient surgical centers and large anesthesia practices and am very pleased to now be a part of ACMR,” said Dr. Plavin. “We are evaluating a new, reproducible acute pain model that is potentially less invasive and intrusive than the current standard, which should provide an advantage in conducting effective trials for pain therapeutics in the future.”
“With over twenty years of experience in the perioperative environment, Dr. Plavin will help ACMR facilitate the safe and appropriate delivery of any clinical trial requiring surgical or anesthetic intervention,” said Sarah Kazmi, MD, Vice President and General Manager of ACMR.
“We’re glad to add Dr. Plavin’s resources to our exceptional group of principal investigators,” said Tom Wardle, CEO of CenExel. “We are also excited that our ACMR site joins JBR Clinical Research – another of our Centers of Excellence – as the only two sites in the world selected to study a novel gene therapy in the treatment of lumbosacral radiculopathy, or sciatic nerve compression pain. Dr. Plavin’s experience will be instrumental in helping us to conduct that trial.”
Media Contact: media@CenexelResearch.com
About CenExel Clinical Research
CenExel Clinical Research (www.CenexelResearch.com) provides unparalleled medical and scientific support in the design and execution of clinical trials. Their attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. CenExel Centers of Excellence have conducted thousands of studies, the variety and complexity of which have resulted in a great depth of experience and insight for the principal investigators and research staff in each facility. The CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that clients achieve their clinical research goals.
About the Atlanta Center for Medical Research
ACMR (www.acmr.org) is a fully dedicated 100,000 square foot, state-of-the-art research facility. We provide conscientious, recruitment-driven medical research services that are pivotal in the advancement and treatment of illnesses of the central nervous system and other therapeutic areas. Our dedicated and experienced research teams conduct clinical trials with compassion and respect for our study participants. We are a CenExel Center of Excellence, assuring unparalleled patient engagement, staff expertise, and valuable results.